Navigation Links
EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial
Date:11/10/2008

ibition of the mTOR/rictor pathway. The Akt-mTOR pathway is the most frequently mutated pathway in human tumors and mutations have been shown to promote tumor progression and decrease survival in cancer patients. EntreMed Vice President and Chief Medical Officer, Carolyn F. Sidor, M.D., M.B.A., commented on the study, "We are pleased to have met the primary efficacy endpoint in the first stage of this study. We are now considering whether to continue the current study or pursue additional options such as a randomized Phase 2 study in patients with non-small cell lung cancer. We will continue to collect data over the next few months from patients participating in this trial to determine the most efficient path forward in this indication."

Alimta(R) is a registered trademark of its owner and is not a registered trademark of EntreMed, Inc.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. MKC-1, an oral cell-cycle regulator with activity against the mTOR pathway, is currently in multiple Phase 2 clinical trials for cancer. ENMD-2076, a selective angiogenic kinase inhibitor, and ENMD-1198, a novel antimitotic agent are in Phase 1 studies in advanced cancers. The Company also has an approved IND application for Panzem(R) in rheumatoid arthritis. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell cycle regulation, cell signaling and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about EntreMed is available on the Company's web site at http://www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the Pr
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer
2. Asenapine Meets Primary Endpoint in Long-Term Schizophrenia Relapse Prevention Trial
3. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
4. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
5. The Science of Music Meets the Art of Medicine - ARIMM 3rd Annual Conference at IPFW, September 12-13, 2008
6. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
7. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
8. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
9. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
10. World Think Tank on Type 1 Diabetes Meets in Miami
11. Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... (PRWEB) May 22, 2013 iLuv Creative ... of accessories for the mobile lifestyle, announces they are ... protect, and manage multiple iPad devices efficiently. Winner of ... the 2012 Good Design award, MultiCharger-X is revolutionizing the ... wherever it is deployed. , MultiCharger-X (iAD910) ...
(Date:5/22/2013)...  Empire Genomics announced today it has acquired ... genomic biomarker from Cornell University for use in ... in diagnosing and determining treatment for patients with ... prostate cancer (NEPC) is a lethal variant of ... but more commonly arises after hormonal therapy for ...
(Date:5/22/2013)... May 22, 2013  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today ... Second Annual Marcum LLP Microcap Conference, May 30, in ... Neil Lyons , CPA, Chief Financial Officer of ... on May 30 at 1:30 p.m. Eastern Time.  A live ... on the Investors page of the Cleveland BioLabs website at ...
(Date:5/22/2013)... Alton Housing Authority was hit by bed ... that their presence has already caused the company $35,000 ... such big spending, My Cleaning Products shared a way ... said in the report that to clear the infestation ... that, its employees also attended a mandatory training on bed ...
Breaking Biology Technology:iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2
... research center south of Madison, a group of scientists, ... about the ethical choices presented by biotechnology's expanding knowledge ... be the memory of Terri Schiavo. , ,Every day, ... patients such as Schiavo, the brain-damaged Florida woman who ...
... one person in a crowd who is proud to announce ... compulsive about reading the job classifieds. , ,Don't get me ... between the ubiquitous "excellent communication skills" and the ever popular ... every day, even if it happens to be my first ...
... maker of automotive and facility ... Pro-Tel Inc. for an undisclosed ... contracting company founded in 1961 ... employees. Its repair and maintenance ...
Cached Biology Technology:Schiavo's death calls attention to ethical issues weighed at Bioethics Forum 2Schiavo's death calls attention to ethical issues weighed at Bioethics Forum 3Is IT leadership a position or an attitude? 2Is IT leadership a position or an attitude? 3
(Date:5/21/2013)... the way genes function without changing the underlying ... blood of pregnant women during any trimester, potentially ... the weeks after giving birth, and an opportunity ... findings of the small study involving 52 pregnant ... Molecular Psychiatry . , "Postpartum depression can be ...
(Date:5/20/2013)... ITHACA, N.Y. Little is known about the effect ... new study from Cornell University finds that increasing the ... class reduces the probability of obesity. , The study ... effect of PE on youth obesity, and is forthcoming ... An early, online version of the study can be ...
(Date:5/20/2013)... URBANA - A National Science Foundation (NSF) planning grant ... Drying (CARD), a joint program of the University of ... Worcester, Mass. , "CARD will be devoted to research ... other agricultural products; forestry and paper products; chemical products; ... I professor of food science and human nutrition and ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3Gym class reduces probability of obesity, study finds for first time 2NSF approves planning grant for Center for Advanced Research in Drying 2
... of patients in the study cohort receiving anti-tumour necrosis ... a first cancer within nine years and overall risk ... The nine year follow-up study conducted at Gentofte University ... 0.82-1.30)) was not increased in patients treated with anti-TNFs ...
... University of Warwick have discovered why a newly found ... increased risk of heart disease. The discovery could lead ... people with type 2 diabetes and the elderly. ... found that ,ultrabad, cholesterol, called MGmin-low-density lipoprotein (LDL), which ...
... Conflicts and misunderstandings frequently arise between individuals from ... one more restrictive and another less so? A ... and supported by the National Science Foundation,s Division of ... explain such cultural differences and bridge the gaps between ...
Cached Biology News:Arthritis patients taking newer treatments do not have an overall increased cancer risk 2Super-sticky 'ultra-bad' cholesterol revealed in people at high risk of heart disease 2World-wide assessment determines differences in cultures 2World-wide assessment determines differences in cultures 3
... recent sequencing of Salmonella genomes has allowed ... ORFmer PCR* primer pairs. The S. enterica ... single chromosome (4,857,432 bp; 4,440 ORFs) and ... These ORFmers from Sigma-Genosys have been designed ...
... designed for easy transformation of the budding ... successful transformation simply by mixing a plasmid ... yeast cells. No complicated steps, such as ... kit is particularly well suited for high-throughput ...
... Microplate Handler is a high-capacity, plug-and-play ... BioTeks washers, readers and liquid handling ... ultimate flexibility and intuitive and powerful ... to single devices or linking several ...
... balance makes your life easier. It offers a wide ... for one balance. *Instruments supported: ... UMX, AG, XS, XP, PR, SR, PG-S, PG, SG, ... User guidance on ...
Biology Products: